Primary central nervous system lymphoma: age and performance status are more important than treatment modality
- 1 June 1998
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 41 (3) , 615-620
- https://doi.org/10.1016/s0360-3016(97)00571-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapyNeurology, 1996
- Leptomeningeal tumor in primarchy central nervous system lymphoma: Recognition, significance, and implicationsAnnals of Neurology, 1995
- Incidence, clinicopathological features and outcome of primary central nervous system lymphomasAnnals of Oncology, 1994
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992
- Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy aloneInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Primary CNS lymphomaNeurology, 1990
- High-dose methotrexate for non-AIDS primary central nervous system lymphomaJournal of Neurosurgery, 1989
- Primary lymphoma of the central nervous systemCancer, 1982
- Radiation therapy in the management of primary malignant lymphoma of the brainInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Reticulum cell sarcoma of the brain.A review of the literature and a study of 19 casesCancer, 1975